ROCKET PHARMACEUTICALS, INC. — All Filings
898 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
3/A
305B2
4
4/A
424B2
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFM14A
DEL AM
DRS
DRS/A
EFFECT
FWP
POS AM
PRE 14A
PREM14A
PRER14A
PX14A6G
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001140361-24-011168 | Mar 4, 2024 | Feb 29, 2024 |
| 4 | FORM 4 | 0001140361-24-011170 | Mar 4, 2024 | Feb 29, 2024 |
| 144 | — | 0001959173-24-001588 | Feb 29, 2024 | — |
| 144 | — | 0001959173-24-001578 | Feb 29, 2024 | — |
| 10-K | 10-K | 0000950170-24-021096 | Feb 27, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0001140361-24-009506 | Feb 26, 2024 | — |
| 4 | FORM 4 | 0001140361-24-008888 | Feb 21, 2024 | Feb 16, 2024 |
| 4 | FORM 4 | 0001140361-24-008889 | Feb 21, 2024 | Feb 16, 2024 |
| 4 | FORM 4 | 0001140361-24-008890 | Feb 21, 2024 | Feb 16, 2024 |
| 4 | FORM 4 | 0001140361-24-008886 | Feb 21, 2024 | Feb 16, 2024 |
| 4 | FORM 4 | 0001140361-24-008887 | Feb 21, 2024 | Feb 16, 2024 |
| 144/A | — | 0001959173-24-001136 | Feb 16, 2024 | — |
| 4 | FORM 4 | 0001140361-24-008357 | Feb 16, 2024 | Feb 14, 2024 |
| 144 | — | 0001959173-24-001126 | Feb 16, 2024 | — |
| 4 | FORM 4 | 0001140361-24-008360 | Feb 16, 2024 | Feb 14, 2024 |
| 4 | FORM 4 | 0001140361-24-008358 | Feb 16, 2024 | Feb 14, 2024 |
| 4 | FORM 4 | 0001140361-24-008359 | Feb 16, 2024 | Feb 14, 2024 |
| 144 | — | 0001959173-24-001116 | Feb 16, 2024 | — |
| 144 | — | 0001959173-24-001119 | Feb 16, 2024 | — |
| 144 | — | 0001959173-24-001123 | Feb 16, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021855 | Feb 13, 2024 | — |
| 8-K | 8-K | 0001140361-24-007462 | Feb 13, 2024 | — |
| SC 13G | SEC SCHEDULE 13G | 0000902219-24-000121 | Feb 8, 2024 | — |
| SC 13G/A | — | 0001086364-24-005099 | Jan 29, 2024 | — |
| 4 | FORM 4 | 0001140361-24-003421 | Jan 23, 2024 | Jan 22, 2024 |
| 144 | — | 0001959173-24-000383 | Jan 22, 2024 | — |
| 4 | FORM 4 | 0001140361-24-003111 | Jan 22, 2024 | Jan 18, 2024 |
| 8-K | 8-K | 0001140361-23-057478 | Dec 13, 2023 | Dec 7, 2023 |
| 3 | — | 0001140361-23-057388 | Dec 12, 2023 | Dec 7, 2023 |
| 4 | — | 0001140361-23-057390 | Dec 12, 2023 | Dec 7, 2023 |
| 4 | — | 0001140361-23-053713 | Nov 16, 2023 | Nov 15, 2023 |
| 144 | — | 0001959173-23-004816 | Nov 16, 2023 | — |
| 144 | — | 0001959173-23-004815 | Nov 16, 2023 | — |
| 144 | — | 0001959173-23-004817 | Nov 16, 2023 | — |
| 4 | FORM 4 | 0001140361-23-053705 | Nov 16, 2023 | Nov 14, 2023 |
| 4 | — | 0001140361-23-053709 | Nov 16, 2023 | Nov 14, 2023 |
| 4 | — | 0001140361-23-053711 | Nov 16, 2023 | Nov 14, 2023 |
| 10-Q | 10-Q | 0000950170-23-060339 | Nov 7, 2023 | Sep 30, 2023 |
| 4 | — | 0001140361-23-049426 | Oct 25, 2023 | Oct 20, 2023 |
| 4/A | — | 0001140361-23-049079 | Oct 20, 2023 | Feb 17, 2023 |
| 144 | — | 0001959173-23-004381 | Oct 20, 2023 | — |
| 4 | — | 0001140361-23-047589 | Oct 10, 2023 | Oct 5, 2023 |
| 4 | — | 0001140361-23-046452 | Oct 2, 2023 | Sep 28, 2023 |
| 8-K | 8-K | 0001140361-23-046302 | Oct 2, 2023 | — |
| 424B5 | 424B5 | 0001140361-23-044609 | Sep 20, 2023 | — |
| SC 13D/A | ROCKET PHARMACEUTICALS, INC. | 0000902664-23-004826 | Sep 19, 2023 | — |
| 4 | — | 0000902664-23-004827 | Sep 19, 2023 | Sep 15, 2023 |
| 8-K | FORM 8-K | 0001140361-23-044141 | Sep 15, 2023 | Sep 12, 2023 |
| 424B5 | 424B5 | 0001140361-23-043843 | Sep 13, 2023 | — |
| 8-K | 8-K | 0001140361-23-043736 | Sep 13, 2023 | Sep 12, 2023 |